Clinica Baviera (XMAD:CBAV) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:CBAV Clinica Baviera SA XMAD:CBAV
100 GF Score
Price €56.60
GF Value €41.42
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clinica Baviera FFO per Share?

FFO per Share only applies to REITs.

XMAD:CBAV
100GF Score
Clinica Baviera SA XMAD:CBAV
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €56.60 is trading 36.6% above its estimated GF Value™ of €41.42. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for XMAD:CBAV:

  • FFO per Share:
  • GF Value™: €41.42 vs. price of €56.60 (36.6% above fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinica Baviera Business Description

Other Exchanges 0GWJ:UKD9Z:Germany
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
100GF Score

Get the complete analysis for XMAD:CBAV

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.60
Price
€41.42
GF Value